Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Healthy

Interventions

DRUG

ODM-104

DRUG

Placebo

DRUG

Entacapone

entacapone + levodopa/carbidopa

DRUG

levodopa/carbidopa

entacapone + levodopa/carbidopa

Trial Locations (1)

Parexel International GmbH, Berlin

All Listed Sponsors

lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT01840423 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers | Biotech Hunter | Biotech Hunter